Search for: "Eli Lilly "
Results 1701 - 1720
of 2,131
Sorted by Relevance
|
Sort by Date
27 Sep 2017, 9:01 pm
McKinney, who received a bachelor’s degree in agricultural economics in 1981, previously was director of global corporate affairs for Elanco Animal Health, a subsidiary of Eli Lilly and Company. [read post]
18 Nov 2011, 6:51 am
And this week the IPKat has also learned the details of the Competition Law Association's Golding Essay Prize, courtesy of his still-technically-young friend Christopher Stothers (Arnold & Porter): Following the Supreme Court’s judgment in Eli Lilly v Human Genome Sciences (noted here), a prize of £1,000 is to be awarded for an essay of up to 5,000 words submitted by a student, trainee solicitor, pupil barrister, devil barrister (from Scotland),… [read post]
8 Nov 2007, 12:21 pm
[PDF] Eastman Kodak Company [PDF] Eli Lilly and Company [PDF] IBM Corporation [DOC] Microsoft Corporation [DOC] Wyeth [DOC] C. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) Trileptal (Oxacarbazepine) - Israel Patent Office prevents Novartis from submitting empirical evidence in patent opposition case (IP Factor) Vesicare (Solifenacin) – US: Astellas files patent infringement lawsuit against Teva over generic Vesicare (GenericsWeb) Zyprexa (Olanzapine) – Canada: Teva Novopharm invalidates Eli Lilly’s Canadian patent for Olanzapine (IP Factor)… [read post]
21 May 2018, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
7 Aug 2008, 4:54 am
The Federal Circuit explained that its conclusion "achieves the same kind of fit, or symmetry" that the Supreme Court spoke of in the Eli Lilly v. [read post]
11 Aug 2009, 3:26 am
Eli Lilly). [read post]
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment: Wyeth v Kappos (Patently-O)… [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter &… [read post]
28 May 2024, 11:54 am
Novo Nordisk and Eli Lilly filed notices of appearance. [read post]
27 Sep 2010, 12:32 pm
Eli Lilly and Co., manufacturer of Thimerosal, began tests on the product back in the 1930s and some say the company suppressed important information on the toxicity of thimerosal until now. [read post]
18 Nov 2015, 6:46 am
With Canada already facing a $500 million lawsuit from Eli Lilly over its patent rules, the TPP could usher in a wave of claims focused on challenges to flexible copyright rules, privacy protections, and net neutrality regulations. [read post]
11 Nov 2011, 11:00 am
The PCAOB staff is digesting the information gleaned from the Task Force before putting out any guidance in this area.SAG member Arnold Hanish of Eli Lilly noted that this area poses significant audit risk and should have a high priority. [read post]
25 Oct 2008, 12:15 pm
Karen Horn, a director since September 2006, also sits on the boards of Eli Lilly and Company, Simon Property Group, all T. [read post]
2 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
26 Mar 2012, 3:21 am
In 2009, Eli Lilly and Co. shelled out $1.4 billion to settle charges that it marketed Zyprexa to nursing homes, among other health-care providers, as a sleep aid. [read post]
26 Sep 2008, 7:44 pm
Eli Lilly & Company announced that starting next year it intended to post an online database of all its payments to doctors for speaking and consulting services. [read post]
22 Jul 2014, 10:17 am
While AndroGel (Abbvie/Abbott) is one of the most popular of these treatments, they also include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/Glaxo) Testopel (Auxilium) The gist of it is that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age… [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany: Düsseldorf… [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based… [read post]
